Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT Therapeutics AS Director's Dealing 2023

Dec 1, 2023

3600_dirs_2023-12-01_5966c8eb-1498-44f3-a34e-76e04010c6c8.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Notification of transactions by Primary Insiders and Close Associates

1 Details of the Primary Insider/Close Associate
a) Name Per Walday
2
a) Position/status The notification concerns a Primary insider: Per Walday
(CEO)
b) Initial notification/
Amendment
Initial notification
3 Details of Nordhealth AS, emission allowance market participant, auction platform,
auctioneer or auction monitor
a) Name EXACT Therapeutics AS
b) LEI 2138006ZE5JAL39AGD55
4
a) Description of the Nature of the instrument: Share
financial instrument, type
of instrument Instrument of identification code (ISIN): NO 0010852213
Identification code
b) Nature of the transaction Disposal
c) Price(s) and volume(s) Price(s) Volume(s)
12
per share
8,333
d) Aggregated information Price: 99,996
Volume: 8,333
- Aggregated volume
- Price
e) Date of the transaction 2023-11-30
f) Place of the transaction Oslo Børs